BioMed Realty Bolsters West Coast Market Operations by Appointing 30-Year Real Estate Veteran Bob Nowak as Senior Vice President

San Diego, CA (December 3, 2024) - BioMed Realty, a Blackstone portfolio company and the largest private operator of life science real estate, announced today that Bob Nowak has joined the Company as Senior Vice PresidentofOperations for West Coast Markets.

Mr. Nowak will lead the operations and facilities functions across the West Coast markets, which include San Diego, the San Francisco Bay Area, Seattle and Boulder. He will be based at the Company’s headquarters in San Diego. Mr. Nowak brings 30 years of commercial real estate operations and asset management experience to BioMed Realty. He most recently served as Managing Director at Jones Lang LaSalle (JLL).

“We are thrilled to welcome Bob to BioMed Realty and look forward to the value he will bring to our West Coast tenants,” said Jon Bergschneider, President of West Coast Markets. “His deep expertise and leadership in real estate operations and management will be a great addition and help continue to drive BioMed Realty’s success. His collaborative nature and focus on maintaining and growing client relationships aligns with our approach to providing exceptional service in support of our business at BioMed Realty.”

“I am excited to join BioMed Realty,” Mr. Nowak said. “I share the Company’s commitment to providing the highest level of service critical to the incredibly important work in which our tenants engage across multiple areas of research and innovation. I look forward to working alongside our operations team to address the unique needs of our current and future clients in the life science and technology industries.”

Prior to joining JLL in 2013, Mr. Nowak served as Chief Operating Officer at Means Knaus Partners. Mr. Nowak holds a Bachelor of Science degree in Political Science from Arizona State University and an MBA from University of Colorado’s Leeds School of Business.

December 3, 2024

BioMed Realty, a Blackstone portfolio company, is a leading provider of real estate solutions to the life science and technology industries. BioMed owns and operates high quality life science real estate comprising—as of September 30, 2024—16 million square feet concentrated in leading innovation markets throughout the US and UK, including Boston/Cambridge, San Francisco, San Diego, Seattle, Boulder and Cambridge, UK. In addition, BioMed maintains a premier in-process development platform with 2.5 million square feet of Class A properties in active construction to meet the growing demand of the life science and technology industries. To learn more about BioMed Realty, visit biomedrealty.com and follow the company on X @biomedrealty.